Medicaid ABA Therapy Funding Grew Since 2019

Annual Medicaid billing for Applied Behavioral Analysis therapy rose from $400 million to nearly $2 billion by 2024.

Updated on Sept. 23, 2026 in Autism

Isometric editorial illustration of a modern clinic structure, depicting institutional growth in healthcare services.
Annual Medicaid billing for Applied Behavioral Analysis therapy grew from $400 million to nearly $2 billion between 2019 and 2024. AI Illustration. Upload story photo >

Live Poll

Do you trust private equity firms to manage healthcare services in the best interest of patients?

Annual Medicaid billing for Applied Behavioral Analysis (ABA) therapy in the United States surged between 2019 and 2024. During this period, costs climbed from $400 million to nearly $2 billion.

Why it matters

The rapid increase in spending reflects both greater utilization of therapy services and the significant influence of private equity investment in the sector. Many of the largest providers of these services are now backed by such firms.

Medicaid billing for Applied Behavioral Analysis therapy grew from $400 million in 2019 to nearly $2 billion by 2024. It remains unclear how much of this fivefold increase is due to higher patient volume versus changes in billing practices.

The details

Private equity firms have increasingly moved into the behavioral health space, acquiring and backing numerous large-scale providers of Applied Behavioral Analysis. This infusion of capital coincided with the significant expansion in total Medicaid funding allocated for these services nationwide.

Timeline

  1. Medicaid billing for therapy grew between 2019 and 2024.

The Big Picture

The rise in Applied Behavioral Analysis therapy billing follows the broader financial trajectory seen across the Medicaid program as state and federal administrators manage surging service costs. This report highlights a specific sector within the program that has experienced rapid, multi-year expenditure growth.

The expansion of private equity-backed providers may change how families access therapy and the types of care facilities available in their communities. Patients and their guardians should monitor how corporate consolidation influences service availability and insurance coverage.

The takeaway

Families navigating therapy options should verify the stability and credentials of providers as the industry continues to consolidate under private equity backing. Understanding these market shifts can help parents advocate for consistent care standards for their children.

Further reading

Learn more about evolving standards and resources at Autism.

Source note: This article includes information reported by MPR News.

Live Poll

Do you trust private equity firms to manage healthcare services in the best interest of patients?